ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

WILLIAM PATRICK M.D.

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 31

$1.76M Total Retail Price of All Prescriptions

Rank: 2 out of 31

856 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 856 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

27% of this provider’s 856 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 27,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 28.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
WARFARIN SODIUM 1,420 1,289 1 7
FUROSEMIDE 1,211 1,044 2 1
OMEPRAZOLE 889 765 3 3
LISINOPRIL 826 760 4 5
POTASSIUM CHLORIDE 802 710 5 12
MIRTAZAPINE 762 701 6 13
AMLODIPINE BESYLATE 720 674 7 4
LEVOTHYROXINE SODIUM 681 604 8 2
DONEPEZIL HCL 637 604 9 9
SIMVASTATIN 627 510 10 6
TRAMADOL HCL 608 567 11 25
METOPROLOL TARTRATE 601 562 12 8
HYDROCODONE-ACETAMINOPHEN 580 533 S3 13 11
POLYETHYLENE GLYCOL 3350 533 459 14 28
GABAPENTIN 478 370 15 14
NAMENDA 464 426 16 16
LANTUS 436 375 17 21
ZOLPIDEM TARTRATE 389 342 18 30
CITALOPRAM HBR 380 305 19 10
JANTOVEN 365 365 20 64
NOVOLOG 331 293 21 35
METOPROLOL SUCCINATE 322 299 22 20
SERTRALINE HCL 312 261 23 15
RISPERIDONE 311 236 24 26
OXYCODONE-ACETAMINOPHEN 281 223 S2 25 61
FAMOTIDINE 267 233 26 56
TAMSULOSIN HCL 257 222 27 26
QUETIAPINE FUMARATE 253 229 28 37
CARVEDILOL 249 205 29 29
CYMBALTA 246 174 30 47
PANTOPRAZOLE SODIUM 236 194 31 34
ESCITALOPRAM OXALATE 232 206 32 41
ATENOLOL 228 200 33 24
PROMETHAZINE HCL 227 201 R 34 65
PRAVASTATIN SODIUM 223 201 35 18
DIVALPROEX SODIUM 219 172 36 36
FENTANYL 216 186 S2 37 54
KLOR-CON M20 211 187 38 42
HUMALOG 205 158 39 85
RANITIDINE HCL 196 154 40 33
CIPROFLOXACIN HCL 195 173 41 59
LEVOFLOXACIN 187 160 42 94
ATORVASTATIN CALCIUM 181 176 43 22
ADVAIR DISKUS 178 160 44 52
LIDODERM 177 163 45 78
GLIPIZIDE 168 151 46 60
LEVETIRACETAM 165 122 47 75
ALBUTEROL SULFATE 151 126 48 90
DILTIAZEM 24HR CD 149 149 49 68
METFORMIN HCL 147 136 50 19
DIGOXIN 146 137 51 55
LOSARTAN POTASSIUM 145 116 52 23
ALENDRONATE SODIUM 142 120 53 39
HYDRALAZINE HCL 137 93 54 53
CLOPIDOGREL 137 114 54 31
TRAZODONE HCL 132 89 56 32
CEPHALEXIN 129 118 57 106
CARBIDOPA-LEVODOPA 129 116 57 46
LACTULOSE 127 71 59 109
SPIRIVA 123 120 60 51
CLONIDINE HCL 120 100 61 44
HYDROCHLOROTHIAZIDE 118 112 62 17
VALPROIC ACID 118 50 62 174
RAMIPRIL 117 117 64 76
CYCLOBENZAPRINE HCL 117 57 R 64 72
SPIRONOLACTONE 113 87 66 58
ROPINIROLE HCL 111 108 67 79
PREDNISONE 111 96 67 40
NYSTATIN 110 91 69 87
PLAVIX 108 96 70 45
ALLOPURINOL 107 105 71 49
EXELON 104 104 72 77
NITROFURANTOIN MONO-MACRO 102 94 73 185
AZITHROMYCIN 100 90 74 84
OLANZAPINE 100 80 74 70
ENALAPRIL MALEATE 94 86 76 83
VENLAFAXINE HCL 94 80 76 86
ISOSORBIDE MONONITRATE ER 93 76 78 43
SEROQUEL 93 88 78 96
SANTYL 93 70 78 148
DILTIAZEM HCL 90 89 81 143
AMIODARONE HCL 88 83 82 156
NOVOLIN R 88 68 82 105
SYNTHROID 87 75 84 68
GLIMEPIRIDE 87 76 84 50
NIASPAN 86 67 86 121
KLOR-CON M10 84 81 87 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 64 88 74
LEXAPRO 79 75 89 133
SINGULAIR 78 73 90 101
FLUOXETINE HCL 77 75 91 73
DIOVAN 77 65 91 63
NEXIUM 76 64 93 38
MUPIROCIN 75 62 94 163
VENLAFAXINE HCL ER 74 46 95 98
IPRATROPIUM-ALBUTEROL 72 65 96 81
BACLOFEN 71 28 97 92
HUMULIN R 70 69 98 206
OXYBUTYNIN CHLORIDE 70 54 98 159
CRESTOR 67 52 100 67
LANOXIN 67 58 100 208
OXYCODONE HCL 67 57 S2 100 57
BRIMONIDINE TARTRATE 67 59 100 137
PHENYTOIN SODIUM EXTENDED 66 58 104 118
HALOPERIDOL 66 63 104 80
PAROXETINE HCL 66 55 104 104
FLUTICASONE PROPIONATE 65 62 107 47
NYSTATIN-TRIAMCINOLONE 65 64 107 161
JANUVIA 64 61 109 82
NYSTOP 61 54 110 221
TRANSDERM-SCOP 61 50 110 221
COUMADIN 60 43 112 121
BUSPIRONE HCL 60 35 112 138
LANSOPRAZOLE 58 58 114 128
LYRICA 57 45 115 99
AMOXICILLIN 55 46 116 132
NITROGLYCERIN PATCH 54 54 117 165
DOXAZOSIN MESYLATE 54 53 117 130
CEFTRIAXONE 53 40 119 127
PHENYTOIN 53 41 119 241
AGGRENOX 53 53 119 107
GALANTAMINE HBR 52 52 122 184
LABETALOL HCL 52 52 122 116
TRAVATAN Z 51 32 124 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.